The anti-angiogenic activity of nobiletin was correlated with decreased levels of Akt, HIF-1α, NF-κB and vascular epithelial growth factor (VEGF) in ovarian cancer cells. The gene discussed is HIF1A; the disease is ovarian carcinoma.